GlassScriptPhysician profile
Roger Willaim Lewis
NPI 1699876086
$2,164.40
in general payments reported to CMS, 2019-2025
26 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $91.60 · 2021: $253 · 2022: $287 · 2023: $506 · 2024: $489 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.55 |
| Education | $107.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $355.35 | 2023-2025 | |
| Therapeuticsmd, INC. | $275.00 | 2019-2022 | |
| Shield Therapeutics INC | $211.92 | 2023-2024 | Accrufer |
| Astellas Pharma US INC | $210.98 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $150.90 | 2020-2025 | Aptima, Acessa Provu System |
| Myovant Sciences INC. | $122.30 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $120.43 | 2023-2024 | Myfembree |
| Sage Therapeutics, LLC | $80.41 | 2024-2025 | Zurzuvae |
| Organon LLC | $66.91 | 2021-2022 | |
| Aspira Women'S Health INC | $61.27 | 2022-2023 | Ova1 |
| Agile Therapeutics, INC. | $60.15 | 2021-2022 | |
| Evofem Biosciences, INC. | $59.70 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $45.86 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $38.47 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $35.61 | 2019-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $33.31 | 2019-2024 | |
| Mylan Pharmaceuticals INC. | $32.50 | 2021 | |
| Boston Scientific Corporation | $29.97 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $29.93 | 2021-2022 | |
| Allergan, INC. | $27.55 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.56 | 2019 | |
| Meditrina | $21.10 | 2025 | |
| Millicent US INC | $19.60 | 2024 | Femring, Intrarosa |
| Minerva Surgical, INC | $19.15 | 2025 | |
| Coopersurgical, INC. | $16.84 | 2020 | |
| Smith+Nephew, INC. | $15.63 | 2024 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.